Study of safety & efficacy of the combination of LJM716 & BYL719 in patients with previously treated esophageal squamous cell carcinoma (ESCC)

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-005624-15

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To study the safety and efficacy of the combination of LJM716 and BYL719 against currently available treatments of physician’s choice in previously treated ESCC patients


Critère d'inclusion

  • esophageal squamous cell carcinoma